Analysis of multidrug-resistant tuberculosis

R. Yasin, Z. Abu Bakar, A. R. Abdul Muttalif (Kuala Lumpur, Malaysia)

Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 1
Session: Tuberculosis: from epidemiology to therapy 1
Session type: Thematic Poster Session
Number: 2646
Disease area: Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R. Yasin, Z. Abu Bakar, A. R. Abdul Muttalif (Kuala Lumpur, Malaysia). Analysis of multidrug-resistant tuberculosis. Eur Respir J 2014; 44: Suppl. 58, 2646

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The global risk of dying from multidrug-resistant tuberculosis (MDR-TB)
Source: International Congress 2014 – Tuberculosis epidemiology: novel features
Year: 2014

Determinants of multidrug-resistant tuberculosis (MDR-TB) in Belarus
Source: Annual Congress 2012 - MDR- and XDR-TB: epidemiological and public health overview
Year: 2012


Spread of tuberculosis among household contacts of multi drug resistant tuberculosis (MDRTB) patients
Source: International Congress 2014 – Tuberculosis: epidemiology and public health
Year: 2014


Mutations in the genes of drug-resistant mycobacterium tuberculosis in Uzbekistan
Source: International Congress 2014 – Tuberculosis: diagnosis
Year: 2014

Multidrug-resistant tuberculosis (MDR-TB)
Source: Breathe 2010; 6: 283
Year: 2010

Epidemiology of TB
Source: Eur Respir Mon 2012; 58: 14-25
Year: 2012


Management of MDR tuberculosis
Source: Short video discussion 2021
Year: 2021

Genotypes and drug resistance patterns of multi-drug-resistant mycobacterium tuberculosis strains in Pakistan
Source: International Congress 2015 – Non-tuberculous mycobacteria and molecular microbiology
Year: 2015

Extensively drug-resistant tuberculosis (XDR-TB) and multidrug-resistant tuberculosis (MDR-TB): a retrospective comparative study
Source: Annual Congress 2008 - Multidrug-resistant and the emerging threat of extensively drug-resistant tuberculosis
Year: 2008


Surgical treatment of multidrug-resistant tuberculosis (MDR TB)
Source: Eur Respir J 2003; 22: Suppl. 45, 523s
Year: 2003

Management and treatment of multidrug-resistant tuberculosis
Source: International Congress 2019 – Tuberculosis: latest advances and challenges in patient management
Year: 2019


Transmission of mycobacterium tuberculosis Ural 163-15 lineage causing multidrug-resistant tuberculosis among hospitalized patients
Source: International Congress 2015 – Management of TB: a patient focus
Year: 2015

Multidrug-resistant tuberculosis (MDR-TB) and HIV co-infection in Romania
Source: Annual Congress 2011 - Tuberculosis in immunocompromised hosts
Year: 2011


Treatment of TB
Source: Eur Respir Mon 2012; 58: 154-166
Year: 2012


Linezolid in the treatment of patients with MDR TB and XDR TB
Source: Annual Congress 2013 –Drug-resistant tuberculosis
Year: 2013


Treatment of drug-susceptible and drug-resistant tuberculosis
Source: Eur Respir Monogr 2018; 82: 152-178
Year: 2018


Multidrug-resistant tuberculosis
Source: Annual Congress 2008 - The thoracic surgeon facing infection
Year: 2008


Extensively drug-resistant (XDR) pulmonary tuberculosis in HIV negative cases
Source: Annual Congress 2008 - The challenge of multidrug-resistant tuberculosis
Year: 2008

Risk factors for acquired drug-resistant tuberculosis
Source: Annual Congress 2013 –Drug-resistant tuberculosis
Year: 2013